share_log

Aerpio Pharmaceuticals Q2 EPS $(0.09) Down From $0.23 YoY

Aerpio Pharmaceuticals Q2 EPS $(0.09) Down From $0.23 YoY

Aerpio制药公司第二季度每股收益从去年同期的0.23美元下降到0.09美元
Benzinga Real-time News ·  2021/08/11 16:11

Aerpio Pharmaceuticals (NASDAQ:ARPO) reported quarterly losses of $(0.09) per share. This is a 139.13 percent decrease over earnings of $0.23 per share from the same period last year.

Aerpio制药公司(纳斯达克市场代码:ARPO)公布季度每股亏损0.09美元。这比去年同期每股0.23美元的收益下降了139.13%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发